These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 4029097)
1. Effects of polyhalogenated aromatic compounds on porphyrin metabolism. Hill RH Environ Health Perspect; 1985 May; 60():139-43. PubMed ID: 4029097 [TBL] [Abstract][Full Text] [Related]
6. The porphyrias: recent advances. Hindmarsh JT Clin Chem; 1986 Jul; 32(7):1255-63. PubMed ID: 3521939 [TBL] [Abstract][Full Text] [Related]
7. Porphyrinurias and occupational disease. Doss MO Ann N Y Acad Sci; 1987; 514():204-18. PubMed ID: 3327428 [TBL] [Abstract][Full Text] [Related]
8. Toxicity of polychlorinated biphenyl with special reference to porphyrin metabolism. Sano S; Kawanishi S; Seki Y Environ Health Perspect; 1985 Feb; 59():137-43. PubMed ID: 3921356 [TBL] [Abstract][Full Text] [Related]
9. Porphyrins, porphyrin metabolism, porphyrias. III. Diagnosis, care and monitoring in porphyria cutanea tarda--suggestions for a handling programme. Thunell S; Harper P Scand J Clin Lab Invest; 2000 Nov; 60(7):561-79. PubMed ID: 11202050 [TBL] [Abstract][Full Text] [Related]
10. High-dose vitamin E lowers urine porphyrin levels in patients affected by porphyria cutanea tarda. Pinelli A; Trivulzio S; Tomasoni L; Bertolini B; Pinelli G Pharmacol Res; 2002 Apr; 45(4):355-9. PubMed ID: 12030801 [TBL] [Abstract][Full Text] [Related]
11. [Metabolic fate of porphyrin and its precursors in porphyria and porphyrinuria]. Harada K; Ohmori S; Kim Y; Tomokuni K Nihon Rinsho; 1995 Jun; 53(6):1349-56. PubMed ID: 7616646 [TBL] [Abstract][Full Text] [Related]
13. Porphyrins and hepatotoxicity. Kimbrough RD Ann N Y Acad Sci; 1987; 514():289-96. PubMed ID: 3442389 [TBL] [Abstract][Full Text] [Related]
14. Hepatic uroporphyrinogen decarboxylase activity in porphyria cutanea tarda patients: the influence of virus C infection. Moran MJ; Fontanellas A; Brudieux E; Hombrados I; de Ledinghen V; Couzigou P; de Verneuil H; De Salamanca RE Hepatology; 1998 Feb; 27(2):584-9. PubMed ID: 9462661 [TBL] [Abstract][Full Text] [Related]
15. Development of porphyria cutanea tarda after treatment with cyclophosphamide. Manzione NC; Wolkoff AW; Sassa S Gastroenterology; 1988 Oct; 95(4):1119-22. PubMed ID: 3410226 [TBL] [Abstract][Full Text] [Related]
16. Cytochrome P450 induction, uroporphyrinogen decarboxylase depression, porphyrin accumulation and excretion, and gender influence in a 3-week rat model of porphyria cutanea tarda. Franklin MR; Phillips JD; Kushner JP Toxicol Appl Pharmacol; 1997 Dec; 147(2):289-99. PubMed ID: 9439724 [TBL] [Abstract][Full Text] [Related]
17. Urinary porphyrin excretion in children is associated with exposure to organochlorine compounds. Sunyer J; Alvarez-Pedrerol M; To-Figueras J; Ribas-Fitó N; Grimalt JO; Herrero C Environ Health Perspect; 2008 Oct; 116(10):1407-10. PubMed ID: 18941586 [TBL] [Abstract][Full Text] [Related]
18. Alterations in the heme biosynthetic pathway as an index of exposure to toxins. Marks GS; Zelt DT; Cole SP Can J Physiol Pharmacol; 1982 Jul; 60(7):1017-26. PubMed ID: 6812933 [TBL] [Abstract][Full Text] [Related]
19. Acquired and inherited porphyria: clinical and biochemical features. Magnin PH; del C Batlle AM; de Xifra EA; Lenczner M; Parera VE; Stella AM Int J Dermatol; 1982 Apr; 21(3):142-7. PubMed ID: 7085169 [TBL] [Abstract][Full Text] [Related]